Neuropathic pain and neurocognitive functioning in children treated for acute lymphoblastic leukemia

Keyphrases

• Acute Lymphoblastic Leukemia 100%
• Survivors 100%
• Neuropathic Pain 100%
• Neurocognitive Function 100%
• Opioids 60%
• California Verbal Learning Test 60%
• End of Therapy 40%
• Gabapentin 40%
• Clinical Trials 20%
• Working Diagnosis 20%
• Risk Factors 20%
• Treatment-related 20%
• Adjusted Means 20%
• Age-adjusted 20%
• Childhood Acute Lymphoblastic Leukemia 20%
• At-risk 20%
• Re-induction 20%
• Memory Performance 20%
• Memory Impairment 20%
• Contemporary Therapy 20%
• Learning Problems 20%
• Long Delay 20%
• Common Toxicity Criteria 20%
• Sustained Learning 20%
• Parent Ratings 20%
• Neurocognitive Impairment 20%
• Cognitive Impairment 20%
• Attention Memory 20%
• Sustained Attention 20%
• Event Severity 20%
• Nonpharmacological Pain Management 20%
• Neurocognitive Assessment 20%
• Learning Performance 20%
• Psychosocial Outcomes 20%
• Pain Outcomes 20%
• Event Duration 20%
• Attention Learning 20%
• Close Monitoring 20%
• Learning Slope 20%
• Neurocognitive Deficits 20%

Medicine and Dentistry

• Acute Lymphoblastic Leukemia 100%
• Neuropathic Pain 100%
• Opiate 60%
• California Verbal Learning Test 60%
• Gabapentin 40%
• Clinical Trial 20%
• Memory Disorder 20%
• Learning Disorder 20%
• Cognitive Defect 20%
• Analgesia 20%

Neuroscience

• Neuropathic Pain 100%
• California Verbal Learning Test 60%
• Opiate 60%
• Gabapentin 40%
• Learning Disabilities 20%
• Memory Disorder 20%
• Cognitive Disorders 20%